184 related articles for article (PubMed ID: 19101512)
1. BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis.
Hayashi K; Yamaguchi T; Yano S; Kanazawa I; Yamauchi M; Yamamoto M; Sugimoto T
Biochem Biophys Res Commun; 2009 Feb; 379(2):261-6. PubMed ID: 19101512
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
Kanazawa I; Yamaguchi T; Yano S; Hayashi K; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Aug; 41(8):612-6. PubMed ID: 19384817
[TBL] [Abstract][Full Text] [Related]
4. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2.
Luppen CA; Leclerc N; Noh T; Barski A; Khokhar A; Boskey AL; Smith E; Frenkel B
J Biol Chem; 2003 Nov; 278(45):44995-5003. PubMed ID: 12933820
[TBL] [Abstract][Full Text] [Related]
5. Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways.
Zhao R; Tao L; Qiu S; Shen L; Tian Y; Gong Z; Tao ZB; Zhu Y
Life Sci; 2020 Sep; 257():118044. PubMed ID: 32622944
[TBL] [Abstract][Full Text] [Related]
6. Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.
Inoue Y; Hisa I; Seino S; Kaji H
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):719-23. PubMed ID: 20213600
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
8. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.
Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X
Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
10. The epithelial sodium channel is involved in dexamethasone-induced osteoblast differentiation and mineralization.
Lu L; Wu L; Jia H; Li Y; Chen J; Xu D; Li Q
Cell Biol Toxicol; 2012 Oct; 28(5):279-89. PubMed ID: 22752439
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.
Takase H; Yano S; Yamaguchi T; Kanazawa I; Hayashi K; Yamamoto M; Yamauchi M; Sugimoto T
Horm Metab Res; 2009 Dec; 41(12):861-5. PubMed ID: 19672814
[TBL] [Abstract][Full Text] [Related]
12. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
13. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.
Liu S; Fang T; Yang L; Chen Z; Mu S; Fu Q
Int J Mol Med; 2018 Apr; 41(4):2059-2069. PubMed ID: 29393365
[TBL] [Abstract][Full Text] [Related]
14. Positive interaction between 17 beta-Estradiol and parathyroid hormone in normal human osteoblasts cultured long term in the presence of dexamethasone.
Rao LG; Kung Sutherland MS; Muzaffar SA; Wylie JN; McBroom RJ; Murray TM
Osteoporos Int; 1996; 6(2):111-9. PubMed ID: 8704348
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid Suppresses Connexin 43 Expression by Inhibiting the Akt/mTOR Signaling Pathway in Osteoblasts.
Shen C; Kim MR; Noh JM; Kim SJ; Ka SO; Kim JH; Park BH; Park JH
Calcif Tissue Int; 2016 Jul; 99(1):88-97. PubMed ID: 26914606
[TBL] [Abstract][Full Text] [Related]
17. Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling.
Wang Y; Chen J; Chen J; Dong C; Yan X; Zhu Z; Lu P; Song Z; Liu H; Chen S
Toxicol Appl Pharmacol; 2020 Dec; 409():115333. PubMed ID: 33171191
[TBL] [Abstract][Full Text] [Related]
18. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells.
Hong D; Chen HX; Xue Y; Li DM; Wan XC; Ge R; Li JC
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):86-92. PubMed ID: 19460432
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone downregulates the expression of parathyroid hormone-related protein (PTHrP) in mesenchymal stem cells.
Ahlström M; Pekkinen M; Lamberg-Allardt C
Steroids; 2009 Feb; 74(2):277-82. PubMed ID: 19121329
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of PTH receptor mRNA expression by dexamethasone in UMR-106 osteoblast-like cells.
Haramoto N; Kawane T; Horiuchi N
Oral Dis; 2007 Jan; 13(1):23-31. PubMed ID: 17241426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
